Clinical Trial

Exploring the Use of Genetic and Behavioural Data in Tailoring Dietary and Lifestyle Support

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Personalised nutrition approaches typically rely on static information such as health status, lifestyle and genetic data. However, adherence often remains low because daily behaviours are influenced by psychological states, motivation and real-time barriers. There is growing interest in whether integrating behavioural signals and timely prompts could strengthen engagement. The purpose of this study is to explore whether incorporating psychological adaptation and just-in-time behavioural prompts leads to better adherence to a personalised nutrition programme compared with commonly used personalised approach (combining health, lifestyle and genetics data without psycho-behavioural adaptation). Using a six-week n-of-1 randomised trial design implemented across multiple participants, the research will also assess the feasibility of delivering this adaptive support in a free-living environment, as well as participants' engagement, acceptability and perceived usefulness. Following completion of the 6-week intervention, an optional focus group will be conducted with a subset of participants (maximum 8) within four weeks of the final study day. The focus group will last approximately 60-90 minutes and will be conducted in person or via video call. Qualitative data from the focus group will be analysed using reflexive thematic analysis (Braun \& Clarke, 2021). These findings will inform the development of an adaptive personalised nutrition AI agent.
Protocol Amendment History 3 changes
notable Primary completion pushed: 2026-06 -> 2026-07 2026-07-21
minor Completion pushed: 2026-06 -> 2026-07 2026-07-21
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-05-02
Trial Details
NCT Number NCT07407556
Lead Sponsor Alexandra King
Collaborators: Optimyse Nutrition LTD
Conditions Adherence to a Personalised Nutrition Programme
Enrollment 20 participants
Start Date 2026-02-13
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-20